Search Results - "Vera, Masiel"
-
1
In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy
Published in Frontiers in immunology (25-09-2023)“…Treatment-free remission (TFR) in patients with chronic myeloid leukemia in chronic phase is considered a safe option if suitable molecular monitoring is…”
Get full text
Journal Article -
2
Elevated plasma levels of IL-6 and MCP-1 selectively identify CML patients who better sustain molecular remission after TKI withdrawal
Published in Journal of hematology and oncology (29-04-2023)“…Treatment-free remission (TFR) in chronic myeloid leukemia (CML) is safe under adequate molecular monitoring, but questions remain regarding which factors may…”
Get full text
Journal Article -
3
High Level of Successful TKI Discontinuation in Chronic Myeloid Leukemia (CML) Patients: Preliminary Results of AST-Argentina Stop Trial
Published in Blood (05-11-2020)“…Introduction: Treatment-free remission (TFR) is an emerging treatment goal for chronic myeloid leukemia (CML) patients in deep molecular response (DMR)…”
Get full text
Journal Article -
4
In Pursuit of Surrogate Markers for Treatment-Free Remission in Patients with Chronic Myeloid Leukemia from Argentina Stop Trial
Published in Blood (05-11-2020)“…Long-term survival of patients with chronic myeloid leukemia (CML) has significantly improved since the introduction of BCR-ABL1 tyrosine kinase inhibitors…”
Get full text
Journal Article